Sofinnova Venture Partners IX, L.P.

13D and 13G Filings

13D/G filings
13D on 1 security, 13G on 1 security
Location
Menlo Park, CA
CIK
0001612133
Form D filings
1 filing
All SEC filings
View on sec.gov
Issuer % of Class Filed
Schedule 13D · 1 security · may seek to influence control
NextCure, Inc. 13D/A
NXTC · 65343E207
7.1% 3/5/2026
Event 12/19/2025
Schedule 13G · 1 security · passive
ArriVent Biopharma, Inc. 13G/A
AVBP · 04272N102
4.1% 3/5/2026
Event 12/31/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.